摘要
股骨粗隆间骨折是创伤骨科常见髋部骨折类型。合并糖尿病的老年股骨粗隆间骨折患者在围手术期需要一定时期的卧床制动,由于合并基础疾病往往具有较高的下肢深静脉血栓(deep vein thrombosis,DVT)形成的风险性,而DVT又是此类患者围手术期致残率、致死率较高的并发症之一,严重者可继发致死性肺动脉血栓栓塞症(PTE)。利伐沙班因其应用方便、无须常规检测凝血功能、与药物及食物相互作用少以及具有可靠的抗凝作用等优点,逐渐成为老年糖尿病患者创伤骨折术后预防DVT形成的新型口服抗凝药物。
Femoral intertrochanteric fracture is a common type of hip fracture in clinical trauma surgery.Elderly femoral intertrochanteric fracture patients combined with diabetes mellitus usually require a period to keep lying in bed for forbiding activity in the perioperative period.This condition leads to high risk of deep vein thrombosis,which is a complication with high disability and high mortality rate.More seriously,the deep vein thrombosis can be secondary to the pulmonary thromboembolism（PTE）.Rivaroxaban gradually becomes the new oral intake of anticoagulant for the aged diabetes mellitus patients after the orthopaedics operation because of many advantages such as convenient application,no requirement of determining coagulation function,lower interaction with others medicines and food,and reliable anticoagulation.
出处
《创伤外科杂志》
2011年第6期564-566,共3页
Journal of Traumatic Surgery
关键词
股骨粗隆间骨折
利伐沙班
静脉血栓
糖尿病
femoral intertrochanteric fracture
Rivaroxaban
vein thrombosis
diabetes mellitus
